{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:46:14Z","timestamp":1792125974932,"version":"4.4.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JSS Academy of Higher Education and Research, Mysore","id":[{"id":"https:\/\/ror.org\/013x70191","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["3 Biotech"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disorder that predominantly affects elderly people and is characterized by cognitive decline and dementia. Protein tyrosine phosphatase-1B (PTP1B) is known to modulate pro-inflammatory mediators, and its overexpression in the brain has been implicated in AD-associated neuroinflammation. This study explores the mechanism of A20, A26, and co-crystal-designed compound targeting non-competitive allosteric PTP1B enzyme inhibition for AD therapy using network pharmacology and computational studies. Protein-protein interaction was designed for 128 active targets by STRING database and Cytoscape software. Further, active target-associated pathways analysed using ClueGO plugin Cytoscape software and the Reactome online public domain server. The non-competitive allosteric PTP1B inhibition through the design of Simufilam derivatives, with particular emphasis on A20, which is predicted to bind at the non-competitive allosteric site of the PTP1B protein (PDB ID: 1T49), involves \u03b13, \u03b16, and \u03b17 helices that influence the WPD loop orientation. The proposed non-competitive allosteric binding mode is based on computational evidence and for that further experimental validation would be required to conclusively confirm binding of the designed compounds within this regulatory region. Using in-silico approaches, including molecular docking, identified A20 with the most favourable predicted binding energy score (\u221210.8\u00a0kcal\/mol) compared to other derivatives. Molecular dynamics simulations further indicated structural stability of the PTP1B-A20, 26, and co-crystal complex, with consistent RMSD, RMSF, H-bond, Rg, and SASA. Principal component analysis suggested that A20 restricts conformational flexibility; hence MM-PBSA analysis displayed its stable binding free energies. Density functional theory (DFT) calculation characterized the polarity, stability, and reactivity of A20 studies supported its favourable electronic configuration. Overall, A20 displayed superior calculated binding energies, trajectory stability, and predicted drug-likeness, positioning it as a promising lead candidate for future empirical validation in AD research.<\/jats:p>","DOI":"10.1007\/s13205-026-05086-2","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:08:14Z","timestamp":1792123694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Network pharmacology\u2013driven identification of PTP1\u03b2 and rational design of simufilam-based allosteric inhibitors for neuroprotection in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"16","author":[{"given":"Vishnu","family":"Malakar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshkumar","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1015-8317","authenticated-orcid":false,"given":"Antony","family":"Justin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanabal","family":"SP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhritiman","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandi C.","family":"Malakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipen","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratap Chand","family":"Mali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"5086_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R et al (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"key":"5086_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101936","volume":"32","author":"T Abu-Izneid","year":"2024","unstructured":"Abu-Izneid T, Rauf A, Ahmad Z et al (2024) Density functional theory (DFT), molecular docking, and xanthine oxidase inhibitory studies of dinaphthodiospyrol S from Diospyros kaki L. Saudi Pharm J 32:101936. https:\/\/doi.org\/10.1016\/j.jsps.2023.101936","journal-title":"Saudi Pharm J"},{"key":"5086_CR3","doi-asserted-by":"publisher","DOI":"10.2174\/011570159X446831260303200516","author":"MD Abubakar","year":"2026","unstructured":"Abubakar MD, Alom S, Ali F et al (2026) Molecular Mechanisms of Dopaminergic Neuron Degeneration in Parkinson\u2019s disease: A Comprehensive Review. Curr Neuropharmacol. https:\/\/doi.org\/10.2174\/011570159X446831260303200516","journal-title":"Curr Neuropharmacol"},{"key":"5086_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","volume":"281","author":"M Agrawal","year":"2018","unstructured":"Agrawal M, Saraf S, Saraf S et al (2018) Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Controlled Release 281:139\u2013177. https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.011","journal-title":"J Controlled Release"},{"key":"5086_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104707","volume":"135","author":"A Akhtar","year":"2020","unstructured":"Akhtar A, Sah SP (2020) Insulin signaling pathway and related molecules: role in neurodegeneration and Alzheimer\u2019s disease. Neurochem Int 135:104707. https:\/\/doi.org\/10.1016\/j.neuint.2020.104707","journal-title":"Neurochem Int"},{"key":"5086_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.136695","volume":"1295","author":"KJ Al-Adilee","year":"2024","unstructured":"Al-Adilee KJ, Jawad SH, Kyhoiesh HAK, Hassan HM (2024) Synthesis, characterization, biological applications, and molecular docking studies of some transition metal complexes with azo dye ligand derived from 5-methyl imidazole. J Mol Struct 1295:136695. https:\/\/doi.org\/10.1016\/j.molstruc.2023.136695","journal-title":"J Mol Struct"},{"key":"5086_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.hsr.2022.100039","volume":"4","author":"R Ali","year":"2022","unstructured":"Ali R, Gupta GD, Chawla PA (2022) Aducanumab: a new hope in Alzheimer\u2019s disease. Health Sci Rev 4:100039. https:\/\/doi.org\/10.1016\/j.hsr.2022.100039","journal-title":"Health Sci Rev"},{"key":"5086_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11696-025-04126-0","author":"VK Aslam Mohd, Malakar","year":"2025","unstructured":"Aslam Mohd, Malakar VK, Nand B et al (2025) A comparative in silico study of noscapine, bosutinib, and the co-crystal ligand (DHHE) of 3B99 to investigate their interaction with prostacyclin synthase. Chem Pap. https:\/\/doi.org\/10.1007\/s11696-025-04126-0","journal-title":"Chem Pap"},{"key":"5086_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.24198\/ijcb.v2i1.46322","volume":"2","author":"U Baroroh SSi, MBiotek","year":"2023","unstructured":"Baroroh SSi, MBiotek U, Muscifa ZS, Destiarani W et al (2023) Molecular interaction analysis and visualization of protein-ligand docking using Biovia Discovery Studio Visualizer. Indonesian J Comput Biology (IJCB) 2:22. https:\/\/doi.org\/10.24198\/ijcb.v2i1.46322","journal-title":"Indonesian J Comput Biology (IJCB)"},{"key":"5086_CR200","doi-asserted-by":"publisher","unstructured":"Birks J, Harvey RJ (2006) Donepezil for dementia due to Alzheimer\u2019s disease. Cochrane Database Syst Rev https:\/\/doi.org\/10.1002\/14651858.CD001190.pub2","DOI":"10.1002\/14651858.CD001190.pub2"},{"key":"5086_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1021\/ct900549r","volume":"6","author":"P Bjelkmar","year":"2010","unstructured":"Bjelkmar P, Larsson P, Cuendet MA et al (2010) Implementation of the CHARMM force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models. J Chem Theory Comput 6:459\u2013466. https:\/\/doi.org\/10.1021\/ct900549r","journal-title":"J Chem Theory Comput"},{"key":"5086_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.abb.2012.06.002","volume":"525","author":"TAS Brand\u00e3o","year":"2012","unstructured":"Brand\u00e3o TAS, Johnson SJ, Hengge AC (2012) The molecular details of WPD-loop movement differ in the protein-tyrosine phosphatases YopH and PTP1B. Arch Biochem Biophys 525:53\u201359. https:\/\/doi.org\/10.1016\/j.abb.2012.06.002","journal-title":"Arch Biochem Biophys"},{"key":"5086_CR12","doi-asserted-by":"publisher","first-page":"100467","DOI":"10.1016\/j.lana.2023.100467","volume":"20","author":"R Brockmann","year":"2023","unstructured":"Brockmann R, Nixon J, Love BL, Yunusa I (2023) Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer\u2019s disease: patient outcomes, healthcare costs, and drug development. Lancet Reg Health - Americas 20:100467. https:\/\/doi.org\/10.1016\/j.lana.2023.100467","journal-title":"Lancet Reg Health - Americas"},{"key":"5086_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1389014","author":"G Carbone","year":"2024","unstructured":"Carbone G, Bencivenga L, Santoro MA et al (2024) Impact of serum leptin and adiponectin levels on brain infarcts in patients with mild cognitive impairment and Alzheimer\u2019s disease: a longitudinal analysis. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2024.1389014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5086_CR14","doi-asserted-by":"publisher","first-page":"8257","DOI":"10.1021\/cr500127b","volume":"114","author":"EM Carreira","year":"2014","unstructured":"Carreira EM, Fessard TC (2014) Four-Membered Ring-Containing Spirocycles: Synthetic Strategies and Opportunities. Chem Rev 114:8257\u20138322. https:\/\/doi.org\/10.1021\/cr500127b","journal-title":"Chem Rev"},{"key":"5086_CR15","doi-asserted-by":"crossref","unstructured":"Cen Y, Alves SR, Song D et al (2025) PTP1B inhibition promotes microglial phagocytosis in Alzheimer\u2019s disease models by enhancing SYK signaling","DOI":"10.1101\/2025.05.30.657101"},{"key":"5086_CR16","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1016\/S0960-894X(02)00757-6","volume":"12","author":"RM Chen","year":"2002","unstructured":"Chen RM, Hu LH, An TY et al (2002) Natural PTP1B Inhibitors from broussonetia papyrifera. Bioorg Med Chem Lett 12:3387\u20133390. https:\/\/doi.org\/10.1016\/S0960-894X(02)00757-6","journal-title":"Bioorg Med Chem Lett"},{"key":"5086_CR17","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.molcel.2017.01.014","volume":"65","author":"MS Choy","year":"2017","unstructured":"Choy MS, Li Y, Machado LESF et al (2017a) Conformational Rigidity and Protein Dynamics at Distinct Timescales Regulate PTP1B Activity and Allostery. Mol Cell 65:644\u2013658e5. https:\/\/doi.org\/10.1016\/j.molcel.2017.01.014","journal-title":"Mol Cell"},{"key":"5086_CR18","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1523\/JNEUROSCI.21-04-01179.2001","volume":"21","author":"CK Combs","year":"2001","unstructured":"Combs CK, Karlo JC, Kao S-C, Landreth GE (2001) \u03b2-Amyloid Stimulation of Microglia and Monocytes Results in TNF\u03b1-Dependent Expression of Inducible Nitric Oxide Synthase and Neuronal Apoptosis. J Neurosci 21:1179\u20131188. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-04-01179.2001","journal-title":"J Neurosci"},{"key":"5086_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","volume":"19","author":"EE Congdon","year":"2023","unstructured":"Congdon EE, Ji C, Tetlow AM et al (2023) Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol 19:715\u2013736. https:\/\/doi.org\/10.1038\/s41582-023-00883-2","journal-title":"Nat Rev Neurol"},{"key":"5086_CR202","doi-asserted-by":"publisher","unstructured":"Cummings J, Zhou Y, Lee G, et al (2023) Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions 9. https:\/\/doi.org\/10.1002\/trc2.12385","DOI":"10.1002\/trc2.12385"},{"key":"5086_CR201","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, et al (2023) Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med 388:9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"key":"5086_CR20","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J Chem Inf Model 61:3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203","journal-title":"J Chem Inf Model"},{"key":"5086_CR21","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","volume":"380","author":"MF Egan","year":"2019","unstructured":"Egan MF, Kost J, Voss T et al (2019) Randomized Trial of Verubecestat for Prodromal Alzheimer\u2019s Disease. N Engl J Med 380:1408\u20131420. https:\/\/doi.org\/10.1056\/NEJMoa1812840","journal-title":"N Engl J Med"},{"key":"5086_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00894-015-2622-4","volume":"21","author":"E Esmaili","year":"2015","unstructured":"Esmaili E, Shahlaei M (2015) Analysis of the flexibility and stability of the structure of magainin in a bilayer, and in aqueous and nonaqueous solutions using molecular dynamics simulations. J Mol Model 21:73. https:\/\/doi.org\/10.1007\/s00894-015-2622-4","journal-title":"J Mol Model"},{"key":"5086_CR23","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3233\/JAD-215423","volume":"85","author":"F Fan","year":"2022","unstructured":"Fan F, Liu H, Shi X et al (2022) The Efficacy and Safety of Alzheimer\u2019s Disease Therapies: An Updated Umbrella Review. J Alzheimer\u2019s Disease 85:1195\u20131204. https:\/\/doi.org\/10.3233\/JAD-215423","journal-title":"J Alzheimer\u2019s Disease"},{"key":"5086_CR24","doi-asserted-by":"publisher","first-page":"8427","DOI":"10.1021\/acs.jpcb.2c05423","volume":"126","author":"AJ Friedman","year":"2022","unstructured":"Friedman AJ, Liechty ET, Kramer L et al (2022) Allosteric Inhibition of PTP1B by a Nonpolar Terpenoid. J Phys Chem B 126:8427\u20138438. https:\/\/doi.org\/10.1021\/acs.jpcb.2c05423","journal-title":"J Phys Chem B"},{"key":"5086_CR25","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.17219\/acem\/176051","volume":"33","author":"Y Gao","year":"2024","unstructured":"Gao Y, Liu Y, Li Y (2024) Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer\u2019s disease: A systematic review and meta-analysis. Adv Clin Experimental Med 33:1179\u20131187. https:\/\/doi.org\/10.17219\/acem\/176051","journal-title":"Adv Clin Experimental Med"},{"key":"5086_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2022.118901","volume":"354","author":"S Ghahremanian","year":"2022","unstructured":"Ghahremanian S, Rashidi MM, Raeisi K, Toghraie D (2022) Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: a structural review. J Mol Liq 354:118901. https:\/\/doi.org\/10.1016\/j.molliq.2022.118901","journal-title":"J Mol Liq"},{"key":"5086_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/jne.12138","volume":"26","author":"S Gomes","year":"2014","unstructured":"Gomes S, Martins I, Fonseca ACRG et al (2014) Protective Effect of Leptin and Ghrelin against Toxicity Induced by Amyloid-\u03b2 Oligomers in a Hypothalamic cell Line. J Neuroendocrinol 26:176\u2013185. https:\/\/doi.org\/10.1111\/jne.12138","journal-title":"J Neuroendocrinol"},{"key":"5086_CR28","doi-asserted-by":"publisher","first-page":"20303","DOI":"10.1021\/acsomega.2c07542","volume":"8","author":"SJB Grijaldo","year":"2023","unstructured":"Grijaldo SJB, Alvarez MRS, Heralde FM et al (2023) Integrating computational methods in network pharmacology and in silico screening to uncover multi-targeting phytochemicals against aberrant protein glycosylation in lung cancer. ACS Omega 8:20303\u201320312. https:\/\/doi.org\/10.1021\/acsomega.2c07542","journal-title":"ACS Omega"},{"key":"5086_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","volume":"89","author":"H Hampel","year":"2021","unstructured":"Hampel H, Vassar R, De Strooper B et al (2021) The \u03b2-secretase BACE1 in Alzheimer\u2019s disease. Biol Psychiatry 89:745\u2013756. https:\/\/doi.org\/10.1016\/j.biopsych.2020.02.001","journal-title":"Biol Psychiatry"},{"key":"5086_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0299238","volume":"19","author":"AKMM Huq","year":"2024","unstructured":"Huq AKMM, Roney M, Dubey A et al (2024) Phenolic compounds of Theobroma cacao L. show potential against dengue RdRp protease enzyme inhibition by In-silico docking, DFT study, MD simulation and MMGBSA calculation. PLoS One 19:e0299238. https:\/\/doi.org\/10.1371\/journal.pone.0299238","journal-title":"PLoS One"},{"key":"5086_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22101574","volume":"22","author":"S Ishak","year":"2017","unstructured":"Ishak S, Aris S, Halim K et al (2017) Molecular dynamic simulation of space and earth-grown crystal structures of thermostable T1 lipase Geobacillus zalihae revealed a better structure. Molecules 22:1574. https:\/\/doi.org\/10.3390\/molecules22101574","journal-title":"Molecules"},{"key":"5086_CR205","doi-asserted-by":"publisher","unstructured":"Jain V, Bharti S (2025) Mechanistic Insights into Long-Chain PFAS-Induced Toxicity: An In Silico Study Using Network Pharmacology, Molecular Docking, and Molecular Dynamics. J Indian Chem Soc 102261. https:\/\/doi.org\/10.1016\/j.jics.2025.102261","DOI":"10.1016\/j.jics.2025.102261"},{"key":"5086_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep20766","volume":"6","author":"T Jin","year":"2016","unstructured":"Jin T, Yu H, Huang X-F (2016) Selective binding modes and allosteric inhibitory effects of lupane triterpenes on protein tyrosine phosphatase 1B. Sci Rep 6:20766. https:\/\/doi.org\/10.1038\/srep20766","journal-title":"Sci Rep"},{"key":"5086_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-026-05760-9","author":"A Jindal","year":"2026","unstructured":"Jindal A, Rai SN (2026) Targeting autophagy, ferroptosis, and neuroinflammation: polyphenol-mediated modulation of emerging signaling pathways in neurodegeneration. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-026-05760-9","journal-title":"Mol Neurobiol"},{"key":"5086_CR34","doi-asserted-by":"publisher","DOI":"10.2174\/011570159X415585260303184042","author":"M Kaushik","year":"2026","unstructured":"Kaushik M, Potdar M, Madeswaraguptha P et al (2026a) Mitochondrial function in neurons and glia in health and its alteration in Parkinson\u2019s disease: a review. Curr Neuropharmacol. https:\/\/doi.org\/10.2174\/011570159X415585260303184042","journal-title":"Curr Neuropharmacol"},{"key":"5086_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-026-04837-5","volume":"16","author":"M Kaushik","year":"2026","unstructured":"Kaushik M, Vanangamudi M, Sharma S et al (2026b) From nutrients to health outcomes: integrating diet, disease risk, and lifelong wellness. 3 Biotech 16:206. https:\/\/doi.org\/10.1007\/s13205-026-04837-5","journal-title":"3 Biotech"},{"key":"5086_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jics.2025.102008","volume":"102","author":"A Kharwar","year":"2025","unstructured":"Kharwar A, Vel\u00e1zquez-Mart\u00ednez CA, Tiwari AK (2025) Machine learning-assisted in silico discovery of PDE10A inhibitors: integration of QSAR modeling, docking and MD simulations. J Indian Chem Soc 102:102008. https:\/\/doi.org\/10.1016\/j.jics.2025.102008","journal-title":"J Indian Chem Soc"},{"key":"5086_CR204","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/alz.12213","volume":"17","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Jones DT, Greicius MD (2021) Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimer\u2019s & Dementia 17:696\u2013701. https:\/\/doi.org\/10.1002\/alz.12213","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"5086_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R et al (2017) The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47:566-581.e9. https:\/\/doi.org\/10.1016\/j.immuni.2017.08.008","journal-title":"Immunity"},{"key":"5086_CR38","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nchembio.1528","volume":"10","author":"N Krishnan","year":"2014","unstructured":"Krishnan N, Koveal D, Miller DH et al (2014) Targeting the disordered C terminus of PTP1B with an allosteric inhibitor. Nat Chem Biol 10:558\u2013566. https:\/\/doi.org\/10.1038\/nchembio.1528","journal-title":"Nat Chem Biol"},{"key":"5086_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240044","volume":"15","author":"GS Kumar","year":"2020","unstructured":"Kumar GS, Page R, Peti W (2020) The mode of action of the protein tyrosine phosphatase 1B inhibitor Ertiprotafib. PLoS One 15:e0240044. https:\/\/doi.org\/10.1371\/journal.pone.0240044","journal-title":"PLoS One"},{"key":"5086_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.658312","author":"A Kumari","year":"2021","unstructured":"Kumari A, Mittal L, Srivastava M et al (2021) Conformational characterization of the co-activator binding site revealed the mechanism to achieve the bioactive state of FXR. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2021.658312","journal-title":"Front Mol Biosci"},{"key":"5086_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratic\u00f2 D (2020) Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1867:118664. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118664","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"5086_CR42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jmgm.2005.05.006","volume":"24","author":"RJ Law","year":"2005","unstructured":"Law RJ, Capener C, Baaden M et al (2005) Membrane protein structure quality in molecular dynamics simulation. J Mol Graph Model 24:157\u2013165. https:\/\/doi.org\/10.1016\/j.jmgm.2005.05.006","journal-title":"J Mol Graph Model"},{"key":"5086_CR43","doi-asserted-by":"publisher","first-page":"9418","DOI":"10.1021\/acs.jpcb.4c04901","volume":"128","author":"JA Lemkul","year":"2024","unstructured":"Lemkul JA (2024) Introductory Tutorials for Simulating Protein Dynamics with GROMACS. J Phys Chem B 128:9418\u20139435. https:\/\/doi.org\/10.1021\/acs.jpcb.4c04901","journal-title":"J Phys Chem B"},{"key":"5086_CR44","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1007\/s12035-015-9369-x","volume":"53","author":"S-L Liu","year":"2016","unstructured":"Liu S-L, Wang C, Jiang T et al (2016) The Role of Cdk5 in Alzheimer\u2019s Disease. Mol Neurobiol 53:4328\u20134342. https:\/\/doi.org\/10.1007\/s12035-015-9369-x","journal-title":"Mol Neurobiol"},{"key":"5086_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-019-0063-8","volume":"4","author":"P-P Liu","year":"2019","unstructured":"Liu P-P, Xie Y, Meng X-Y, Kang J-S (2019) History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease. Signal Transduct Target Ther 4:29. https:\/\/doi.org\/10.1038\/s41392-019-0063-8","journal-title":"Signal Transduct Target Ther"},{"key":"5086_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137027","volume":"23","author":"R Liu","year":"2022","unstructured":"Liu R, Mathieu C, Berthelet J et al (2022) Human protein tyrosine phosphatase 1B (PTP1B): from structure to clinical inhibitor perspectives. Int J Mol Sci 23:7027. https:\/\/doi.org\/10.3390\/ijms23137027","journal-title":"Int J Mol Sci"},{"key":"5086_CR47","first-page":"701","volume":"42","author":"MI Lobanov","year":"2008","unstructured":"Lobanov MI, Bogatyreva NS, Galzitskaia OV (2008) [Radius of gyration is indicator of compactness of protein structure]. Molekuliarnaia biologiia 42:701\u2013706","journal-title":"Molekuliarnaia biologiia"},{"key":"5086_CR48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/104012371803000307","volume":"30","author":"S Lu","year":"2018","unstructured":"Lu S, Nasrallah HA (2018) The use of memantine in neuropsychiatric disorders: An overview. Ann Clin Psychiatry 30:234\u2013248","journal-title":"Ann Clin Psychiatry"},{"key":"5086_CR49","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1021\/ci400071x","volume":"53","author":"T Makarewicz","year":"2013","unstructured":"Makarewicz T, Ka\u017amierkiewicz R (2013) Molecular Dynamics Simulation by GROMACS Using GUI Plugin for PyMOL. J Chem Inf Model 53:1229\u20131234. https:\/\/doi.org\/10.1021\/ci400071x","journal-title":"J Chem Inf Model"},{"key":"5086_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202403082","author":"V Malakar","year":"2025","unstructured":"Malakar V, Dhanabal S, Gowramma B et al (2025a) Deciphering potent protein tyrosine phosphatase-1B inhibitors through in silico molecular docking, MMGBSA, and molecular dynamics. ChemistrySelect. https:\/\/doi.org\/10.1002\/slct.202403082","journal-title":"ChemistrySelect"},{"key":"5086_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202403078","author":"V Malakar","year":"2025","unstructured":"Malakar V, Dhanabal S, Justin A et al (2025b) Exploring the multi-target effects of Valeriana officinalis in Alzheimer\u2019s disease: a network pharmacology approach. ChemistrySelect. https:\/\/doi.org\/10.1002\/slct.202403078","journal-title":"ChemistrySelect"},{"key":"5086_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-025-04509-5","volume":"50","author":"VK Malakar","year":"2025","unstructured":"Malakar VK, Roy D, Malakar CC et al (2025c) Targeting IDO1 in Huntington\u2019s disease: network pharmacology and preclinical evidence from Coffea arabica. Neurochem Res 50:263. https:\/\/doi.org\/10.1007\/s11064-025-04509-5","journal-title":"Neurochem Res"},{"key":"5086_CR53","doi-asserted-by":"publisher","first-page":"111507","DOI":"10.1016\/j.compbiomed.2026.111507","volume":"204","author":"V Malakar","year":"2026","unstructured":"Malakar V, Dhanabal SP, Roy D et al (2026a) Network pharmacology and computational-based approaches to activate NRF2 pathway via KEAP1 and GSK-3\u03b2 inhibition: Exploring the possible molecular insights of mangiferin for Alzheimer\u2019s. Comput Biol Med 204:111507. https:\/\/doi.org\/10.1016\/j.compbiomed.2026.111507","journal-title":"Comput Biol Med"},{"key":"5086_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-026-04526-y","author":"V Malakar","year":"2026","unstructured":"Malakar V, Malakar CC, Mali PC, Poddar NK (2026b) Targeting protein\u2013protein interactions in the BCL-2 family: opportunities for precision oncology. Clin Transl Oncol. https:\/\/doi.org\/10.1007\/s12094-026-04526-y","journal-title":"Clin Transl Oncol"},{"key":"5086_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-47343-7","author":"V Malakar","year":"2026","unstructured":"Malakar V, Roy D, Dugar N et al (2026c) Computational investigation of biochanin a targeting DEPTOR in Alzheimer\u2019s disease with in vitro cellular validation of neuroprotective activity. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-026-47343-7","journal-title":"Sci Rep"},{"key":"5086_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s11101-026-10240-y","author":"V Malakar","year":"2026","unstructured":"Malakar V, Sankhla B, Malakar CC et al (2026d) Withanolides as molecular inhibitors in oral squamous cell carcinoma: unveiling anticancer mechanisms and therapeutic targets. Phytochem Rev. https:\/\/doi.org\/10.1007\/s11101-026-10240-y","journal-title":"Phytochem Rev"},{"key":"5086_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119264","volume":"10","author":"L Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez L (2015) Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis. PLoS One 10:e0119264. https:\/\/doi.org\/10.1371\/journal.pone.0119264","journal-title":"PLoS One"},{"key":"5086_CR58","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1021\/jm1013693","volume":"54","author":"NA Meanwell","year":"2011","unstructured":"Meanwell NA (2011) Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design. J Med Chem 54:2529\u20132591. https:\/\/doi.org\/10.1021\/jm1013693","journal-title":"J Med Chem"},{"key":"5086_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2022.120851","volume":"369","author":"M Medimagh","year":"2023","unstructured":"Medimagh M, Mleh CB, Issaoui N et al (2023) DFT and molecular docking study of the effect of a green solvent (water and DMSO) on the structure, MEP, and FMOs of the 1-ethylpiperazine-1,4-diium bis(hydrogenoxalate) compound. J Mol Liq 369:120851. https:\/\/doi.org\/10.1016\/j.molliq.2022.120851","journal-title":"J Mol Liq"},{"key":"5086_CR60","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"5086_CR61","doi-asserted-by":"publisher","DOI":"10.1201\/9781003686675","volume-title":"Vitamins and Neurodegeneration","author":"S Nand Rai","year":"2026","unstructured":"Nand Rai S (2026) Vitamins and Neurodegeneration. CRC Press, New York"},{"key":"5086_CR62","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1021\/acs.jcim.4c00136","volume":"64","author":"B Ni","year":"2024","unstructured":"Ni B, Wang H, Khalaf HKS et al (2024) AutoDock-SS: AutoDock for Multiconformational Ligand-Based Virtual Screening. J Chem Inf Model 64:3779\u20133789. https:\/\/doi.org\/10.1021\/acs.jcim.4c00136","journal-title":"J Chem Inf Model"},{"key":"5086_CR63","doi-asserted-by":"publisher","first-page":"746","DOI":"10.2174\/156720512801322564","volume":"9","author":"D Olivares","year":"2012","unstructured":"Olivares D, Deshpande VK, Shi Y et al (2012) N-Methyl D-Aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer\u2019s disease, vascular dementia and Parkinson\u2019s disease. Curr Alzheimer Res 9:746\u2013758. https:\/\/doi.org\/10.2174\/156720512801322564","journal-title":"Curr Alzheimer Res"},{"key":"5086_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17010128","volume":"17","author":"E Ortiz-Islas","year":"2025","unstructured":"Ortiz-Islas E, Montes P, Rodr\u00edguez-P\u00e9rez CE et al (2025) Evolution of Alzheimer\u2019s disease therapeutics: from conventional drugs to medicinal plants, immunotherapy, microbiotherapy and nanotherapy. Pharmaceutics 17:128. https:\/\/doi.org\/10.3390\/pharmaceutics17010128","journal-title":"Pharmaceutics"},{"key":"5086_CR65","doi-asserted-by":"publisher","first-page":"31682","DOI":"10.1074\/jbc.M114.603621","volume":"289","author":"C Ozek","year":"2014","unstructured":"Ozek C, Kanoski SE, Zhang Z-Y et al (2014) Protein-tyrosine phosphatase 1B (PTP1B) is a novel regulator of central brain-derived neurotrophic factor and tropomyosin receptor kinase B (TrkB) signaling. J Biol Chem 289:31682\u201331692. https:\/\/doi.org\/10.1074\/jbc.M114.603621","journal-title":"J Biol Chem"},{"key":"5086_CR66","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","volume":"2","author":"H Pajouhesh","year":"2005","unstructured":"Pajouhesh H, Lenz GR (2005) Medicinal chemical properties of successful central nervous system drugs. NeuroRX 2:541\u2013553. https:\/\/doi.org\/10.1602\/neurorx.2.4.541","journal-title":"NeuroRX"},{"key":"5086_CR67","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-026-04697-z","volume":"16","author":"S Patel","year":"2026","unstructured":"Patel S, Prajapati C, Rai SN, Singh SK (2026) Bridging pathway dysfunction and therapy: novel compounds for neuroprotection. 3 Biotech 16:79. https:\/\/doi.org\/10.1007\/s13205-026-04697-z","journal-title":"3 Biotech"},{"key":"5086_CR68","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0006-8993(94)91598-9","volume":"655","author":"J-J Pei","year":"1994","unstructured":"Pei J-J, Sersen E, Iqbal K, Grundke-Iqbal I (1994) Expression of protein phosphatases (PP-1, PP-2A, PP-2B and PTP-1B) and protein kinases (MAP kinase and P34cdc2) in the hippocampus of patients with Alzheimer disease and normal aged individuals. Brain Res 655:70\u201376. https:\/\/doi.org\/10.1016\/0006-8993(94)91598-9","journal-title":"Brain Res"},{"key":"5086_CR69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbrc.2015.01.040","volume":"458","author":"Z Qin","year":"2015","unstructured":"Qin Z, Pandey NR, Zhou X et al (2015) Functional properties of Claramine: A novel PTP1B inhibitor and insulin-mimetic compound. Biochem Biophys Res Commun 458:21\u201327. https:\/\/doi.org\/10.1016\/j.bbrc.2015.01.040","journal-title":"Biochem Biophys Res Commun"},{"key":"5086_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2023.102537","volume":"12","author":"ST Quayum","year":"2024","unstructured":"Quayum ST, Esha NJI, Siraji S et al (2024) Exploring the effectiveness of flavone derivatives for treating liver diseases: utilizing DFT, molecular docking, and molecular dynamics techniques. MethodsX 12:102537. https:\/\/doi.org\/10.1016\/j.mex.2023.102537","journal-title":"MethodsX"},{"key":"5086_CR71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biopha.2018.11.043","volume":"110","author":"SO Rahman","year":"2019","unstructured":"Rahman SO, Panda BP, Parvez S et al (2019) Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by A\u03b2 peptides in animal model of Alzheimer\u2019s disease. Biomed Pharmacother 110:47\u201358. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.043","journal-title":"Biomed Pharmacother"},{"key":"5086_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jics.2025.102105","volume":"102","author":"C Raksha","year":"2025","unstructured":"Raksha C, Ansiya N, Sivan A (2025) Integrated DFT, topological, and ADME analysis of isatin-based Schiff bases: synthesis and in silico antidiabetic evaluation. J Indian Chem Soc 102:102105. https:\/\/doi.org\/10.1016\/j.jics.2025.102105","journal-title":"J Indian Chem Soc"},{"key":"5086_CR73","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3233\/JAD-190252","volume":"72","author":"PH Reddy","year":"2019","unstructured":"Reddy PH, Swerdlow RH, Culberson J et al (2019) Current Status of Healthy Aging and Dementia Research: A Symposium Summary. J Alzheimer\u2019s Disease 72:S11\u2013S35. https:\/\/doi.org\/10.3233\/JAD-190252","journal-title":"J Alzheimer\u2019s Disease"},{"key":"5086_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-98835-x","volume":"15","author":"A Roy","year":"2025","unstructured":"Roy A, Anbarasu A (2025) Unveiling berberine analogues as potential inhibitors of Escherichia coli FtsZ through machine learning molecular docking and molecular dynamics approach. Sci Rep 15:14668. https:\/\/doi.org\/10.1038\/s41598-025-98835-x","journal-title":"Sci Rep"},{"key":"5086_CR75","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.4c00082","author":"M Saeed","year":"2024","unstructured":"Saeed M, Shoaib A, Tasleem M et al (2024) Role of Alkannin in the Therapeutic Targeting of Protein-Tyrosine Phosphatase 1B and Aldose Reductase in Type 2 Diabetes: An In Silico and In Vitro Evaluation. ACS Omega. https:\/\/doi.org\/10.1021\/acsomega.4c00082","journal-title":"ACS Omega"},{"key":"5086_CR76","doi-asserted-by":"publisher","first-page":"101319","DOI":"10.1016\/j.rechem.2024.101319","volume":"7","author":"A Sarkar","year":"2024","unstructured":"Sarkar A, Concilio S, Sessa L et al (2024) Advancements and novel approaches in modified AutoDock Vina algorithms for enhanced molecular docking. Results Chem 7:101319. https:\/\/doi.org\/10.1016\/j.rechem.2024.101319","journal-title":"Results Chem"},{"key":"5086_CR77","doi-asserted-by":"publisher","first-page":"W463","DOI":"10.1093\/nar\/gkaf361","volume":"53","author":"P Schake","year":"2025","unstructured":"Schake P, Bolz SN, Linnemann K, Schroeder M (2025) PLIP 2025: introducing protein\u2013protein interactions to the protein\u2013ligand interaction profiler. Nucleic Acids Res 53:W463\u2013W465. https:\/\/doi.org\/10.1093\/nar\/gkaf361","journal-title":"Nucleic Acids Res"},{"key":"5086_CR78","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s10571-026-01702-0","volume":"46","author":"OA Sharallah","year":"2026","unstructured":"Sharallah OA, Malakar V, Salama AE et al (2026) Narrative Review Dual Frontiers in Neurodegeneration: Pharmacological Synergies and Divergences in Parkinson\u2019s Disease and Type 2 Diabetes Mellitus. Cell Mol Neurobiol 46:86. https:\/\/doi.org\/10.1007\/s10571-026-01702-0","journal-title":"Cell Mol Neurobiol"},{"key":"5086_CR79","doi-asserted-by":"publisher","first-page":"367","DOI":"10.5377\/nexo.v35i01.13982","volume":"35","author":"M Shekarkhand","year":"2022","unstructured":"Shekarkhand M, Zare K, Monajjemi M et al (2022) Computational study of heterocyclic anticancer compounds through nbo method. Nexo Revista Cient\u00edfica 35:367\u2013381. https:\/\/doi.org\/10.5377\/nexo.v35i01.13982","journal-title":"Nexo Revista Cient\u00edfica"},{"key":"5086_CR203","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD et al (2023) Donanemab in Early Symptomatic Alzheimer Disease. JAMA 330:512. https:\/\/doi.org\/10.1001\/jama.2023.13239","journal-title":"JAMA"},{"key":"5086_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.105626","volume":"121","author":"S Singh","year":"2022","unstructured":"Singh S, Singh Grewal A, Grover R et al (2022) Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders. Bioorg Chem 121:105626. https:\/\/doi.org\/10.1016\/j.bioorg.2022.105626","journal-title":"Bioorg Chem"},{"key":"5086_CR81","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","volume":"367","author":"B Singh","year":"2024","unstructured":"Singh B, Day CM, Abdella S, Garg S (2024) Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management. J Controlled Release 367:402\u2013424. https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.047","journal-title":"J Controlled Release"},{"key":"5086_CR82","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12974-016-0545-3","volume":"13","author":"GJ Song","year":"2016","unstructured":"Song GJ, Jung M, Kim J-H et al (2016) A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation. J Neuroinflammation 13:86. https:\/\/doi.org\/10.1186\/s12974-016-0545-3","journal-title":"J Neuroinflammation"},{"key":"5086_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/ph19020281","volume":"19","author":"A Srivastava","year":"2026","unstructured":"Srivastava A, Renna HA, Hossain T et al (2026) Simufilam in Alzheimer\u2019s disease: assessment of efficacy of a controversial drug in human neuronal cell culture. Pharmaceuticals (Basel) 19:281. https:\/\/doi.org\/10.3390\/ph19020281","journal-title":"Pharmaceuticals (Basel)"},{"key":"5086_CR84","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s40265-020-01268-1","volume":"80","author":"YY Syed","year":"2020","unstructured":"Syed YY (2020) Sodium Oligomannate: First Approval. Drugs 80:441\u2013444. https:\/\/doi.org\/10.1007\/s40265-020-01268-1","journal-title":"Drugs"},{"key":"5086_CR85","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/B978-0-12-815846-3.00095-8","volume-title":"Toxicology Cases for the Clinical and Forensic Laboratory","author":"S Thornton","year":"2020","unstructured":"Thornton S, Crane T (2020) Laboratory confirmed massive donepezil ingestion. Toxicology Cases for the Clinical and Forensic Laboratory. Elsevier, pp 485\u2013487"},{"key":"5086_CR86","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nrm2039","volume":"7","author":"NK Tonks","year":"2006","unstructured":"Tonks NK (2006) Protein tyrosine phosphatases: From genes, to function, to disease. Nat Rev Mol Cell Biol 7:833\u2013846","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5086_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-020-00267-2","volume":"15","author":"MS Vald\u00e9s-Tresanco","year":"2020","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E (2020) AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4. Biol Direct 15:12. https:\/\/doi.org\/10.1186\/s13062-020-00267-2","journal-title":"Biol Direct"},{"key":"5086_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173448","volume":"886","author":"BG Vijayakumar","year":"2020","unstructured":"Vijayakumar BG, Ramesh D, Joji A et al (2020) In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2. Eur J Pharmacol 886:173448. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173448","journal-title":"Eur J Pharmacol"},{"key":"5086_CR89","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/cn100008c","volume":"1","author":"TT Wager","year":"2010","unstructured":"Wager TT, Hou X, Verhoest PR, Villalobos A (2010) Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties. ACS Chem Neurosci 1:435\u2013449. https:\/\/doi.org\/10.1021\/cn100008c","journal-title":"ACS Chem Neurosci"},{"key":"5086_CR90","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.1523\/JNEUROSCI.0354-12.2012","volume":"32","author":"H-Y Wang","year":"2012","unstructured":"Wang H-Y, Bakshi K, Frankfurt M et al (2012) Reducing Amyloid-Related Alzheimer\u2019s Disease Pathogenesis by a Small Molecule Targeting Filamin A. J Neurosci 32:9773\u20139784. https:\/\/doi.org\/10.1523\/JNEUROSCI.0354-12.2012","journal-title":"J Neurosci"},{"key":"5086_CR91","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2017.03.016","volume":"55","author":"H-Y Wang","year":"2017","unstructured":"Wang H-Y, Lee K-C, Pei Z et al (2017) PTI-125 binds and reverses an altered conformation of filamin A to reduce Alzheimer\u2019s disease pathogenesis. Neurobiol Aging 55:99\u2013114. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.03.016","journal-title":"Neurobiol Aging"},{"key":"5086_CR92","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","volume":"29","author":"X Wang","year":"2019","unstructured":"Wang X, Sun G, Feng T et al (2019) Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression. Cell Res 29:787\u2013803. https:\/\/doi.org\/10.1038\/s41422-019-0216-x","journal-title":"Cell Res"},{"key":"5086_CR93","doi-asserted-by":"publisher","first-page":"256","DOI":"10.14283\/jpad.2020.6","volume":"7","author":"H-Y Wang","year":"2020","unstructured":"Wang H-Y, Pei Z, Lee K-C et al (2020) PTI-125 Reduces Biomarkers of Alzheimer\u2019s Disease in Patients. J Prev Alzheimers Dis 7:256\u2013264. https:\/\/doi.org\/10.14283\/jpad.2020.6","journal-title":"J Prev Alzheimers Dis"},{"key":"5086_CR94","doi-asserted-by":"publisher","first-page":"13927","DOI":"10.3390\/ijms241813927","volume":"24","author":"H-Y Wang","year":"2023","unstructured":"Wang H-Y, Cecon E, Dam J et al (2023a) Simufilam Reverses Aberrant Receptor Interactions of Filamin A in Alzheimer\u2019s Disease. Int J Mol Sci 24:13927. https:\/\/doi.org\/10.3390\/ijms241813927","journal-title":"Int J Mol Sci"},{"key":"5086_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2023.1175601","author":"H-Y Wang","year":"2023","unstructured":"Wang H-Y, Pei Z, Lee K-C et al (2023bb) Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer\u2019s disease patient lymphocytes. Front Aging. https:\/\/doi.org\/10.3389\/fragi.2023.1175601","journal-title":"Front Aging"},{"key":"5086_CR96","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nsmb803","volume":"11","author":"C Wiesmann","year":"2004","unstructured":"Wiesmann C, Barr KJ, Kung J et al (2004) Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol 11:730\u2013737. https:\/\/doi.org\/10.1038\/nsmb803","journal-title":"Nat Struct Mol Biol"},{"key":"5086_CR97","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.2147\/CIA.S159920","volume":"13","author":"N Zhang","year":"2018","unstructured":"Zhang N, Gordon ML (2018) Clinical efficacy and safety of donepezil in the treatment of Alzheimer\u2019s disease in Chinese patients. Clin Interv Aging 13:1963\u20131970. https:\/\/doi.org\/10.2147\/CIA.S159920","journal-title":"Clin Interv Aging"},{"key":"5086_CR98","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.foodchem.2009.09.031","volume":"119","author":"J Zhang","year":"2010","unstructured":"Zhang J, Shen Q, Lu J-C et al (2010) Phenolic compounds from the leaves of Cyclocarya paliurus (Batal.) Ijinskaja and their inhibitory activity against PTP1B. Food Chem 119:1491\u20131496. https:\/\/doi.org\/10.1016\/j.foodchem.2009.09.031","journal-title":"Food Chem"},{"key":"5086_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/4245613","volume":"2017","author":"X Zhang","year":"2017","unstructured":"Zhang X, Jiang H, Li W et al (2017) Computational insight into protein tyrosine phosphatase 1B inhibition: a case study of the combined ligand- and structure-based approach. Comput Math Methods Med 2017:1\u201313. https:\/\/doi.org\/10.1155\/2017\/4245613","journal-title":"Comput Math Methods Med"},{"key":"5086_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113188","volume":"151","author":"X Zhao","year":"2022","unstructured":"Zhao X, Xiong L, She L et al (2022) The role and therapeutic implication of protein tyrosine phosphatases in Alzheimer\u2019s disease. Biomed Pharmacother 151:113188. https:\/\/doi.org\/10.1016\/j.biopha.2022.113188","journal-title":"Biomed Pharmacother"}],"container-title":["3 Biotech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-026-05086-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13205-026-05086-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13205-026-05086-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:08:16Z","timestamp":1792123696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13205-026-05086-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":106,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["5086"],"URL":"https:\/\/doi.org\/10.1007\/s13205-026-05086-2","relation":{},"ISSN":["2190-572X","2190-5738"],"issn-type":[{"value":"2190-572X","type":"print"},{"value":"2190-5738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"467"}}